Eastern Bank’s Regenxbio RGNX Stock Holding History

Eastern Bank’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.79K	Hold	370	–	–	﹤0.01%	1016
2026 Q2	$4.43K	Hold	370	–	–	﹤0.01%	930
2026 Q1	$3.1K	Hold	370	–	–	﹤0.01%	976
2025 Q4	$5.33K	Hold	370	–	–	﹤0.01%	957
2025 Q3	$3.57K	Hold	370	–	–	﹤0.01%	934
2025 Q2	$3.04K	Hold	370	–	–	﹤0.01%	860
2025 Q1	$2.65K	Hold	370	–	–	﹤0.01%	905
2024 Q4	$2.86K	Hold	370	–	–	﹤0.01%	871
2024 Q3	$3.88K	Buy	+370	New	+$4.51K	﹤0.01%	834

Other funds holding RGNX

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Eastern Bank's RGNX Position: Q3 2026 in Review

Eastern Bank held its Regenxbio (RGNX) position steady in Q3 2026 at 370 shares worth $2.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Eastern Bank first reported a position in RGNX in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.33K in Q4 2025. 4 funds tracked by Wall St. Rank hold RGNX as of Q3 2026.

Eastern Bank held 370 shares of Regenxbio worth $2.79K as of Q3 2026.
Eastern Bank left its Regenxbio share count unchanged in Q3 2026.
Regenxbio made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #1016 holding.
Eastern Bank first reported a position in Regenxbio in Q3 2024 and has held it in 9 quarters since.
Eastern Bank's Regenxbio position peaked at $5.33K in Q4 2025.
4 funds tracked by Wall St. Rank held Regenxbio as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.